This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Lydia Anderson
Co-Founder at ACTA2 Alliance
Speaker

Profile

Lydia Anderson is a physical therapist, nonprofit cofounder, mother, and rare disease advocate whose life was transformed by her son Raistlin’s ultra-rare genetic condition. Through her family’s experience, she offers a firsthand perspective on the urgent need for effective treatments, including gene therapy, and the real-world impact of delayed progress. Lydia shares a perspective rooted in both challenge and hope.

Agenda Sessions

  • A Family and Patient Perspective on the Urgent Need for Effective Treatments for Ultra-rare Genetic Conditions

    9:45am